Not applicableStudy completedNCT00330538What this trial is testingOsteoporosis in Children With ALLWho this might be right forLeukemia, Lymphocytic, Acute, L1 Children's Mercy Hospital Kansas City 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06652685What this trial is testingMolecular Subtype Combined with Early Minimal Residual Disease to Optimize the Treatment of Newly Diagnosed Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia (AML) Ruijin Hospital 218
Not applicableNot Yet RecruitingNCT07691008What this trial is testingWearable Data for Personalized Prognostication in Cancer: A Registry ProtocolWho this might be right forHematopoietic NeoplasmMalignant Solid NeoplasmLymphatic System Neoplasm+1 more City of Hope Medical Center 1,200
Testing effectiveness (Phase 2)Looking for participantsNCT04742634What this trial is testingPre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell TransplantWho this might be right forMyelodysplastic Syndromes Washington University School of Medicine 209
Testing effectiveness (Phase 2)Study completedNCT00806598What this trial is testingThymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic SyndromeWho this might be right forMyelodysplastic SyndromeAplastic Anemia M.D. Anderson Cancer Center 53
Not applicableStudy completedNCT01338363What this trial is testingDrug Utilization and Safety Events Among Children Using Esomeprazole, Other Proton Pump Inhibitors or H2-receptor AntagonistsWho this might be right forHospitalized Cases of Angioneurotic OedemaPneumoniaGastroenteritis+3 more AstraZeneca 23,470
Testing effectiveness (Phase 2)Ended earlyNCT00909363What this trial is testingThrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) PatientsWho this might be right forWiskott-Aldrich SyndromeThrombocytopeniaBleeding Weill Medical College of Cornell University 24
Testing effectiveness (Phase 2)Study completedNCT03439293What this trial is testingIxazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)Who this might be right forMultiple Myeloma Takeda 61
Not applicableEnded earlyNCT01096121What this trial is testingAngiotensin-converting Enzyme Inhibitors and Early Sickle Cell Renal Disease in ChildrenWho this might be right forSickle Cell Disease Assistance Publique - Hôpitaux de Paris 5
Not applicableWithdrawnNCT05943314What this trial is testingClinical Study on Safety and Efficacy of Anti-CLL1 /+CD33 CAR T Cells in the Treatment of Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Guangzhou Bio-gene Technology Co., Ltd
Not applicableStudy completedNCT01236014What this trial is testingIndirect Comparison Between Eltrombopag & RomiplostimWho this might be right forThrombocytopaenia GlaxoSmithKline 1
Testing effectiveness (Phase 2)WithdrawnNCT00845104What this trial is testingFludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To TreatmentWho this might be right forB-cell Chronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic Leukemia Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Testing effectiveness (Phase 2)UnknownNCT03940833What this trial is testingClinical Research of Adoptive BCMA CAR-NK Cells on Relapse/Refractory MMWho this might be right forMultiple Myeloma Asclepius Technology Company Group (Suzhou) Co., Ltd. 20
Testing effectiveness (Phase 2)Temporarily pausedNCT02910752What this trial is testingCLAM Chemotherapy With PBSC Support for Relapsed Patients After Allogeneic Stem Cell TransplantationWho this might be right forLeukemia Shanghai Jiao Tong University School of Medicine 20
Testing effectiveness (Phase 2)Study completedNCT00866138What this trial is testingMasitinib in Relapse or Refractory Multiple Myeloma With t(4/14) Translocation Expressing or Not FGFR3Who this might be right forMultiple Myeloma AB Science 24
Early research (Phase 1)Looking for participantsNCT07206758What this trial is testingPhase I Study of SHR-2173 Injection in Patients With Primary Immune ThrombocytopeniaWho this might be right forImmune Thrombocytopenia Guangdong Hengrui Pharmaceutical Co., Ltd 10
Early research (Phase 1)Looking for participantsNCT06191978What this trial is testingA Phase Ia/Ib Open-label, Multiple Dose, Study to Determine the Recommended Dose, Evaluate PKs, PDs, Safety, and Activity of Venetoclax in Combination With Oral Decitabine/Cedazuridine (ASTX727) in Pediatric Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)Who this might be right forAcute Myeloid Leukemia M.D. Anderson Cancer Center 40
Large-scale testing (Phase 3)Ended earlyNCT02158936What this trial is testingEltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)Who this might be right forThrombocytopaenia Novartis Pharmaceuticals 356
Not applicableStudy completedNCT02770534What this trial is testingEvaluating Thromboelastography (TEG) and ETP in Sickle AdultsWho this might be right forSickle Cell Disease Guy's and St Thomas' NHS Foundation Trust 100
Early research (Phase 1)Ended earlyNCT06163898What this trial is testingEvaluate Alnuctamab in Combination With Mezigdomide in Participants With Relapsed and/or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Celgene 4